MIST Stock Analysis: Buy, Sell, or Hold?
MIST - Milestone Pharmaceuticals Inc. Common Shares
$1.32
0.03 (2.73%)
▲
5d:
+1.94%
30d:
+3.54%
90d:
-34.25%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When MIST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called MIST this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MIST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: MIST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: MIST is currently trading at $1.31, which is considered oversold relative to its 30-day fair value range of $1.24 to $1.32.
Technical Outlook: Technically, MIST is in a downtrend. Immediate support is located at $1.20, while resistance sits at $1.47.
Market Sentiment: MIST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.33 (+394.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MIST is in a downtrend. Immediate support is located at $1.20, while resistance sits at $1.47.
Market Sentiment: MIST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.33 (+394.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.24 -
$1.32
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 394.8% below Wall St target ($6.33)
Trading Range Analysis
30-Day Trading Range
$1.24 -
$1.32
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.20
Resistance Level
$1.47
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.22
Wall Street Target
$6.33
(+394.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 14, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Oliveto
SELL
36500 shares
2026-04-16
David Bharucha
SELL
12245 shares
2026-01-26
Jeffrey Edward Nelson
SELL
12245 shares
2026-01-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
